Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.

July 31, 2023

Consolidated Financial Results

for the Three Months Ended June 30, 2023

(Under Japanese GAAP)

Company name: Taoka Chemical Co., Ltd

Listing:

Tokyo Stock Exchange

Securities code:

4113

URL:

https://www.taoka-chem.co.jp

Representative:

Yasuaki Sasaki, President

Inquiries:

Yasuhito Katsumoto, General Manager, Business Services Office

Telephone:

+81-6-7639-7400

Scheduled date to file quarterly securities report:

August 9, 2023

Scheduled date to commence dividend payments:

-

Preparation of supplementary material on quarterly financial results: None

Holding of quarterly financial results briefing:

None

(Yen amounts are rounded down to millions, unless otherwise noted.)

1. Consolidated financial results for the three months ended June 30, 2023 (from April 1, 2023 to June 30, 2023)

(1) Consolidated operating results (cumulative)

(Percentages indicate year-on-year changes.)

Net income

Sales revenue

Operating income

Ordinary income

attributable to

owners of the

parent

Three months ended

Millions of

%

Millions of

%

Millions of

%

Millions of

%

yen

yen

yen

yen

June 30, 2023

7,426

(8.8)

2

(98.6)

29

(87.1)

27

(78.9)

June 30, 2022

8,140

(8.7)

203

(75.2)

225

(73.1)

131

(78.2)

Note: Comprehensive income

For the three months ended June 30, 2023: ¥54 million [(66.0)%]

For the three months ended June 30, 2022: ¥159 million [(73.4)%]

Net income

Diluted net income

per share

per share

Three months ended

Yen

Yen

June 30, 2023

1.94

June 30, 2022

9.20

(2) Consolidated financial position

Total assets

Net assets

Equity-to-asset

ratio

As of

Millions of yen

Millions of yen

%

June 30, 2023

30,389

16,496

54.3

March 31, 2023

31,069

16,570

53.3

Reference: Equity

As of June 30, 2023:

¥16,496 million

As of March 31, 2023:

¥16,570 million

2. Cash dividends

Annual dividends per share

First

Second

Third

Fiscal year-

Total

quarter-end

quarter-end

quarter-end

end

Yen

Yen

Yen

Yen

Yen

Fiscal year ended

18.00

9.00

27.00

March 31, 2023

Fiscal year ending

March 31, 2024

Fiscal year ending

March 31, 2024

9.00

9.00

18.00

(Forecast)

Note: Revisions to the forecasts of cash dividends most recently announced: None

3. Consolidated financial forecasts for the fiscal year ending March 31, 2024 (from April 1, 2023 to March 31, 2024)

(Percentages indicate year-on-year changes.)

Net income

Net

attributable to

Sales revenue

Operating income

Ordinary income

income

owners of the

per share

parent

Millions of

%

Millions of

%

Millions of

%

Millions of

%

yen

yen

yen

yen

yen

Second

15,000

(1.7)

150

(39.8)

150

(46.3)

100

(47.7)

6.98

quarter-end

(Cumulative)

Full year

32,000

6.1

700

55.2

700

52.9

400

28.8

27.92

Note: Revisions to the forecasts of consolidated financial results most recently announced: None

* Notes

  1. Changes in significant subsidiaries during the period (changes in specified subsidiaries resulting in the change in scope of consolidation): None
  2. Adoption of accounting treatment specific to the preparation of quarterly consolidated financial statements: Yes
  3. Changes in accounting policies, changes in accounting estimates, and restatement
    1. Changes in accounting policies due to revisions to accounting standards and other regulations: None
    2. Changes in accounting policies due to other reasons: None
    3. Changes in accounting estimates: None
    4. Restatement: None
  4. Number of issued shares (common shares)
    1. Total number of issued shares at the end of the period (including treasury shares)

As of June 30, 2023

As of March 31, 2023

14,440,000 shares

14,440,000 shares

(ii) Number of treasury shares at the end of the period

As of June 30, 2023

As of March 31, 2023

111,140 shares

111,140 shares

  1. Average number of shares outstanding during the period (cumulative from the beginning of the fiscal year)

Three months ended June 30, 2023

Three months ended June 30, 2022

14,328,860 shares

14,328,860 shares

  • Quarterly financial results reports are exempt from quarterly review conducted by certified public accountants or an audit corporation.
  • Proper use of earnings forecasts, and other special matters (Caution regarding forward-looking statements and others)
    The forward-looking statements, including financial forecasts, contained in this report are based on information currently available to the Company and certain assumptions deemed to be reasonable. Accordingly, they are not intended to be construed as assurance that they will be accomplished in the future. Note that actual results may differ materially from the forecasts for a number of reasons.

The Taoka Chemical Group's consolidated sales revenue for the three months ended June 30, 2023, decreased by ¥ 713 million compared with the same period of the previous fiscal year, to ¥7,426 million. The Group posted operating income of ¥ 2 million, ordinary income of ¥ 29 million and net income attributable to owners of the parent of ¥ 27 million.

The financial results of Taoka Chemical by business segment for the three month period were as follows:

Division

Three Months Ended Three Months Ended

Change

June 30, 2022

June 30, 2023

Millions of Composition Millions of Composition Millions of

Year-on-year

yen

ratio (%)

yen

ratio (%)

yen

rate (%)

Fine Chemicals

4,199

51.6

3,616

48.7

(583)

(13.9)

Functional Chemicals

827

10.2

859

11.6

32

3.9

Functional Polymers and

2,971

36.5

2,814

37.9

(156)

(5.3)

Additives

Chemicals Segment

7,997

98.3

7,290

98.2

(707)

(8.8)

Analytical Services

142

1.7

136

1.8

(6)

(4.3)

Total

8,140

100.0

7,426

100.0

(713)

(8.8)

Note: The "Analytical Services," which previously composed the "Others" segment, has been presented as a reportable segment because its quantitative importance has increased.

Chemicals Segment

Sales revenue of this segment was ¥7,290 million, a ¥707 million decrease compared to the same period of the previous fiscal year.

Fine Chemicals Division

Though shipments of agrochemical intermediates increased, shipments of monomers for optical resins decreased. As a result, the division sales revenue decreased by ¥583 million, to ¥3,616 million.

Functional Chemicals Division

A decrease in sales revenue due to a decrease in shipments of rubber additives was outweighed by an increase in sales revenue due to an increase in shipments of adhesives. As a result, the division sales revenue increased by ¥32 million to ¥859 million.

Functional Polymers and Additives Division

Shipments of plasticizers, paper chemicals and varnish decreased. As a result, the division sales revenue decreased by ¥156 million, to ¥2,814 million.

Analytical Services Segment

Sales of asbestos analysis and composition and structural analysis decreased. As a result, the segment sales revenue decreased by ¥6 million, to ¥136 million.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Taoka Chemical Co. Ltd. published this content on 31 July 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 July 2023 07:40:11 UTC.